Previous studies have also found that sustained-release of growth factors (including TGF-β, FEGF, etc.)is an effective strategy to promote cartilage repair and treat TMD (Zheng et al., 2018). This evidence concerns the gene TGFB1 and temporomandibular joint disorder.